Ayurveda management of bronchial asthma in childre
- Conditions
- Health Condition 1: J22- Unspecified acute lower respiratory infection
- Registration Number
- CTRI/2022/08/044803
- Lead Sponsor
- DrShwethaD Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Children of age group 8-12 years, fulfilling the diagnostic criteria, irrespective of gender, religion and socio-economic status.
2.Children with mild to moderate exacerbation of asthma.
3.Children with Covid-19 negative test report(arbitrary).
4.Those parents who are willing to participate their child in the study and ready to sign the assent form.
1.Severe and complicated bronchial asthma those need intense care.
2.Patients on regular Corticosteroids
3.Diagnosed C/O tuberculosis, plueral effusion, emphysema, lung abscess, bronchiectasis, pleurisy, nasal polyps.
4.Congenital lung or cardiac anomalies.
5.Chronic debilitating diseases
6.Children with severe form of asthma with any one of SPO2 < 92%, cyanosis, Silent chest or PEF < 60%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To relieve the obstruction and to increase the functional ability of the lung during the mild to moderate acute episodes of bronchial asthma in children age 8-12 years by spirometric measurement and PEFM using Shati Arka nebulization.Timepoint: The patients will be monitored daily during treatment nebulization before and after each nebulization for 3 days and once after 7days of treatment for relapse of acute <br/ ><br>exacerbation
- Secondary Outcome Measures
Name Time Method To assess the changes in objective parameters like Peak Flow Meter and spirometry measurementsTimepoint: PEF 8th hourly before and after each nebulization <br/ ><br>Spirometry before and after the course of treatment that 3 days;To reduce relapse of acute exacerbationTimepoint: after 1 week